Group 1 - Lexeo Therapeutics, Inc. (LXEO) shares have increased by 3.9% over the past four weeks, closing at $8.52, with a mean price target of $19.11 indicating a potential upside of 124.3% [1] - The mean estimate consists of nine short-term price targets with a standard deviation of $6.6, where the lowest estimate is $9.00 (5.6% increase) and the highest is $30.00 (252.1% increase) [2] - Analysts show strong agreement on LXEO's ability to report better earnings than previously predicted, which supports the potential for stock upside [4][11] Group 2 - The Zacks Consensus Estimate for LXEO's current year earnings has increased by 16.1% over the last 30 days, with four estimates moving higher and no negative revisions [12] - LXEO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting stock gains, they can indicate the direction of price movement, which appears to be a useful guide [14]
Wall Street Analysts Predict a 124.3% Upside in Lexeo Therapeutics, Inc. (LXEO): Here's What You Should Know